Saliva for use with a point of care assay for the rapid diagnosis of COVID-19
- PMID: 32910978
- PMCID: PMC7476885
- DOI: 10.1016/j.cca.2020.09.001
Saliva for use with a point of care assay for the rapid diagnosis of COVID-19
References
-
- Abbott, An update on Abbott's work on COVID-19 testing, 2020. https://www.abbott.com/corpnewsroom/product-and-innovation/an-update-on-... (accessed July 20, 2020).
-
- Harrington A., Cox B., Snowdon J., Bakst J., Ley E., Grajales P., Maggiore J., Kahn S. Comparison of Abbott ID now and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients. J. Clin. Microbiol. 2020 doi: 10.1128/JCM.00798-20:JCM.00798-00720. - DOI - PMC - PubMed
-
- McCormick-Baw C., Morgan K., Gaffney D., Cazares Y., Jaworski K., Byrd A., Molberg K., Cavuoti D. Saliva as an alternate specimen source for detection of SARS-CoV-2 in symptomatic patients using cepheid Xpert Xpress SARS-CoV-2. J. Clin. Microbiol. 2020 doi: 10.1128/JCM.01109-20:JCM.01109-01120. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources